Cardiovascular Diseases, Critical Care, Medication, Outcome, Fatal
Conditions
Brief summary
Cardiovascular treatments should not be interrupted following hospital admission, in order to decrease patients' morbidity. However, following ICU admission, such treatments are frequently interrupted and/or modified. The question of the study is to investigate wether such treatment interruption might be responsible for prognosis modifications.
Detailed description
Cardiovascular treatments should not be interrupted following hospital admission, in order to decrease patients' morbidity. However, following ICU admission, such treatments are frequently interrupted and/or modified. Few studies have investigated the outcome impact of medications interruption and/or modifications following hospital admission. We did consider that it might be interesting to study whether treatment continuation, interruption, and/or re-introduction following ICU admission may modify patients' outcome either in the ICU or following hospital discharge (at 3,6 and 12 months).
Interventions
OTHERObservation
No intervention will be performed
Sponsors
University Hospital, Brest
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All patients with cardiovascular treatment prior to ICU admission
Exclusion criteria
* Data unavailability * Consent withdrawal following information
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ICU Mortality | 2 months following ICU Discharge | Patients mortality will be assessed at the end of the ICU stay (two months) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Hospital mortality | 2 months following Hospital Discharge | Patients mortality will be assessed at the end of the hospitalisation stay (two months) |
| Mortality at Month 3 following discharge | 3-months following discharge | — |
| Mortality at Month 6 following discharge | 6-months following discharge | — |
| Mortality at Month 12 (1-year) following discharge | 12-months following discharge | — |
Countries
France
Contacts
Primary ContactErwan L'HERr
Backup ContactMargot GICQUEL
Outcome results
None listed